Which has the lower trailing P/E, CEPV or DMAA?

DMAA has the lower trailing P/E: CEPV trades at 58.59 and DMAA at 55.53. P/E is one valuation measure and does not by itself establish which business is cheaper.

Cantor Equity Partners V, Inc. Class A Ordinary Shares (CEPV) vs Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

A side-by-side comparison of Cantor Equity Partners V, Inc. Class A Ordinary Shares and Drugs Made In America Acquisition Corp. Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CEPV

Cantor Equity Partners V, Inc. Class A Ordinary Shares

$262M

$10.27Financial ServicesDelayed quote: Oct 5, 2026, 4:00 PM EDT

DMAA

Drugs Made In America Acquisition Corp. Ordinary Shares

$265M

$10.90Financial ServicesDelayed quote: Oct 5, 2026, 1:49 PM EDT

Total return — CEPV vs DMAA

growth of $100 · dividends reinvested · last 1y

CEPV -0.3% (-0.3%/yr)DMAA +5.4% (+5.4%/yr)DMAA compounded faster over this window

CEPV DMAA

CEPV vs DMAA: by the numbers

•DMAA is the larger company ($265M vs $262M market cap).
•DMAA trades at the lower trailing earnings multiple (55.53 vs 58.59 P/E), one valuation lens rather than an overall verdict.

Metrics side by side

Valuation

Metric	CEPV	DMAA
P/E ratio	58.59	55.53
P/B ratio	1.02	1.92

Profitability

Metric	CEPV	DMAA
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	0.00%
ROE	2.18%	4.42%
ROIC	-0.20%	-1.82%

Frequently asked

Which has the lower trailing P/E, CEPV or DMAA?: DMAA has the lower trailing P/E: CEPV trades at 58.59 and DMAA at 55.53. P/E is one valuation measure and does not by itself establish which business is cheaper.

Go deeper

Full CEPV analysis Full DMAA analysis Interactive comparison tool

Dig into the metrics

Cantor Equity Partners V, Inc. Class A Ordinary Shares P/E ratio Drugs Made In America Acquisition Corp. Ordinary Shares P/E ratio Cantor Equity Partners V, Inc. Class A Ordinary Shares ROE Drugs Made In America Acquisition Corp. Ordinary Shares ROE Cantor Equity Partners V, Inc. Class A Ordinary Shares operating margin Drugs Made In America Acquisition Corp. Ordinary Shares operating margin Cantor Equity Partners V, Inc. Class A Ordinary Shares revenue growth Drugs Made In America Acquisition Corp. Ordinary Shares revenue growth Cantor Equity Partners V, Inc. Class A Ordinary Shares free cash flow Drugs Made In America Acquisition Corp. Ordinary Shares free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.